Letter by Sarayani et al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque".

Sarayani, Amir; Jugl, Sebastian; Winterstein, Almut G

Letter by Sarayani et al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque".

Sarayani, Amir; Jugl, Sebastian; Winterstein, Almut G.

Afiliación

Sarayani A; Center for Drug Evaluation and Safety and Department of Pharmaceutical Outcome and Policy, College of Pharmacy, University of Florida, Gainesville.
Jugl S; Center for Drug Evaluation and Safety and Department of Pharmaceutical Outcome and Policy, College of Pharmacy, University of Florida, Gainesville.
Winterstein AG; Center for Drug Evaluation and Safety and Department of Pharmaceutical Outcome and Policy, College of Pharmacy, University of Florida, Gainesville.

Circulation ; 143(25): e1031-e1032, 2021 06 22.

Article en En | MEDLINE | ID: mdl-34152796

Asunto(s)

Enfermedades Cardiovasculares; Placa Aterosclerótica; Enfermedades Cardiovasculares/inducido químicamente; Enfermedades Cardiovasculares/epidemiología; Humanos; Inhibidores de Puntos de Control Inmunológico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Placa Aterosclerótica Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Circulation Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google